Contrasting Innovative Eyewear (NASDAQ:LUCY) & Enovis (NYSE:ENOV)

Enovis (NYSE:ENOV) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings.

Profitability

This table compares Enovis and Innovative Eyewear’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Enovis	-47.96%	12.03%	4.91%
Innovative Eyewear	-272.42%	-83.37%	-76.02%

Risk & Volatility

Enovis has a beta of 1.34, suggesting that its share price is 34% more volatile than the S&P 500. Comparatively, Innovative Eyewear has a beta of 2.72, suggesting that its share price is 172% more volatile than the S&P 500.

Institutional and Insider Ownership

98.5% of Enovis shares are held by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are held by institutional investors. 2.9% of Enovis shares are held by insiders. Comparatively, 1.7% of Innovative Eyewear shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Enovis and Innovative Eyewear, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enovis	1	1	8	0	2.70
Innovative Eyewear	1	1	0	0	1.50

Enovis presently has a consensus target price of $42.00, suggesting a potential upside of 61.02%. Given Enovis’ stronger consensus rating and higher probable upside, equities analysts plainly believe Enovis is more favorable than Innovative Eyewear.

Earnings & Valuation

This table compares Enovis and Innovative Eyewear”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enovis	$2.25 billion	0.67	-$1.18 billion	($19.26)	-1.35
Innovative Eyewear	$2.66 million	1.77	-$7.59 million	($1.69)	-0.43

Innovative Eyewear has lower revenue, but higher earnings than Enovis. Enovis is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.

Summary

Enovis beats Innovative Eyewear on 9 of the 14 factors compared between the two stocks.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

About Innovative Eyewear

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.